Publications by authors named "Johan Beetens"

Claim this Profile
P
Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate-Severe Atopic Dermatitis.
Diamant Thaçi, Dave Singh, Mark Lee, Helen Timmis, Dominique Jacobs, Johan Beetens

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects.
Helen Timmis, Tim Van Kaem, Julie Desrivot, Sonia Dupont, Luc Meuleners, Johan Beetens

Clin Pharmacol Drug Dev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects.
Florence Namour, René Galien, Tim Van Kaem, Annegret Van der Aa, Frédéric Vanhoutte, Johan Beetens

Br J Clin Pharmacol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial.
René Westhovens, Filip De Keyser, Dmytro Rekalov, Evgeny L Nasonov, Johan Beetens

Ann Rheum Dis· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of GLPG0259, a mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5) inhibitor, given as single and multiple doses to healthy male subjects.
Florence Namour, Frédéric P Vanhoutte, Johan Beetens, Stan Blockhuys, Marc De Weer

Drugs R D· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Bram Baert, Eric Deconinck, Mireille Van Gele, Marian Slodicka, Paul Stoppie, Johan Beetens

Bioorg Med Chem· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norpiperidine imidazoazepines as a new class of potent, selective, and nonsedative H1 antihistamines.
Frans Janssens, Jos Leenaerts, Gaston Diels, Benoît De Boeck, Anton Megens, Johan Beetens

J Med Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis